Netherlands Induced Pluripotent Stem Cells (iPSCs) Market to 2032
Overview
The Netherlands Induced Pluripotent Stem Cells (iPSCs) Market is expected to reach a 19.88 USD Million by 2032 and is projected to grow at a CAGR of 6.44% from 2025 to 2032.
Netherlands Induced Pluripotent Stem Cells (iPSCs) Market 2018-2032 USD Million
Netherlands Induced Pluripotent Stem Cells (iPSCs) Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 13.29 USD Million
- Projected Market Size (2032): 19.88 USD Million
- CAGR (2025-2032): 6.44%
Key Findings of Netherlands Induced Pluripotent Stem Cells (iPSCs) Market
- The Netherlands Induced Pluripotent Stem Cells (iPSCs) Market was valued at 13.29 USD Million in 2024.
- The Netherlands Induced Pluripotent Stem Cells (iPSCs) Market is likely to grow at a CAGR of 6.44% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Human iPSCs in Type Segment accounted for the largest share of the market with a revenue of 9.37 USD Million
- The fastest growing segment Biotechnology & Pharmaceutical Companies in End User Segment grew Fastest with a CAGR of 8.78% during the forecast period from 2024 to 2032.
Netherlands Induced Pluripotent Stem Cells (iPSCs) Market Scope
- Blood Cells
- Skin Cells
- Mouse iPSCs
- Human iPSCs
- Instruments
- Services
- Consumables & Kits
- Others
- Diagnostic Laboratories
- Research Laboratories
- Biotechnology & Pharmaceutical Companies
- Retail Sales
- Direct Tender
- Others
- 3D Bioprinting
- Stem Cell Banking
- Toxicology Screening
- Regenerative Medicine
- Cellular Therapy
- Disease Modelling
- Academic Research
- Drug Discovery And Development
Netherlands Induced Pluripotent Stem Cells (iPSCs) Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2022 |
| Unit | Revenue in USD Million |
| Market Value in 2024 | 13.29 USD Million |
| Market Value in 2032 | 19.88 USD Million |
| CAGR (2025-2032) | 6.44% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Cell Source,Type,Product,End User,Distribution Channel,Application |
Regional Insights:
-
Leading Market (2024-2032): Netherlands, leading in terms of revenue 13.29 USD Million in 2024
- Key Country: Netherlands, leading in terms of revenue with value of 13.29 USD Million in 2024.
Segments and Scope
-
Netherlands Induced Pluripotent Stem Cells (iPSCs) Market to 2032, By Cell Source
- Skin Cells is the largest segment in Netherlands Induced Pluripotent Stem Cells (iPSCs) Market to 2032 with a revenue of 8.74 USD Million in the year 2024.
- Skin Cells is the Fastest growing segment in Netherlands Induced Pluripotent Stem Cells (iPSCs) Market to 2032 with a Growth rate of 6.78 % in forecast period 2025-2032.
-
Netherlands Induced Pluripotent Stem Cells (iPSCs) Market to 2032, By Type
- Human iPSCs is the largest segment in Netherlands Induced Pluripotent Stem Cells (iPSCs) Market to 2032 with a revenue of 9.37 USD Million in the year 2024.
- Human iPSCs is the Fastest growing segment in Netherlands Induced Pluripotent Stem Cells (iPSCs) Market to 2032 with a Growth rate of 7.26 % in forecast period 2025-2032.
-
Netherlands Induced Pluripotent Stem Cells (iPSCs) Market to 2032, By Product
- Consumables & Kits is the largest segment in Netherlands Induced Pluripotent Stem Cells (iPSCs) Market to 2032 with a revenue of 6.90 USD Million in the year 2024.
- Consumables & Kits is the Fastest growing segment in Netherlands Induced Pluripotent Stem Cells (iPSCs) Market to 2032 with a Growth rate of 7.53 % in forecast period 2025-2032.
-
Netherlands Induced Pluripotent Stem Cells (iPSCs) Market to 2032, By End User
- Biotechnology & Pharmaceutical Companies is the largest segment in Netherlands Induced Pluripotent Stem Cells (iPSCs) Market to 2032 with a revenue of 6.77 USD Million in the year 2024.
- Biotechnology & Pharmaceutical Companies is the Fastest growing segment in Netherlands Induced Pluripotent Stem Cells (iPSCs) Market to 2032 with a Growth rate of 8.78 % in forecast period 2025-2032.
-
Netherlands Induced Pluripotent Stem Cells (iPSCs) Market to 2032, By Distribution Channel
- Direct Tender is the largest segment in Netherlands Induced Pluripotent Stem Cells (iPSCs) Market to 2032 with a revenue of 8.77 USD Million in the year 2024.
- Direct Tender is the Fastest growing segment in Netherlands Induced Pluripotent Stem Cells (iPSCs) Market to 2032 with a Growth rate of 7.53 % in forecast period 2025-2032.
-
Netherlands Induced Pluripotent Stem Cells (iPSCs) Market to 2032, By Application
- Drug Discovery And Development is the largest segment in Netherlands Induced Pluripotent Stem Cells (iPSCs) Market to 2032 with a revenue of 2.85 USD Million in the year 2024.
- Academic Research is the Fastest growing segment in Netherlands Induced Pluripotent Stem Cells (iPSCs) Market to 2032 with a Growth rate of 6.97 % in forecast period 2025-2032.
Netherlands Induced Pluripotent Stem Cells (iPSCs) Market Company Share Analysis
| Company Name |
|
||
| Merck KGaA | |||
| Lonza | |||
| Thermo Fisher Scientific Inc. | |||
| Evotec SE | |||
| FUJIFILM Corporation | |||
Netherlands Induced Pluripotent Stem Cells (iPSCs) Market Geographical Sales Distribution, 2018-2032 USD Million
Netherlands Induced Pluripotent Stem Cells (iPSCs) Market Company Profiling
Industry Related Reports
Frequently Asked Questions
Coming Soon....
Netherlands Induced Pluripotent Stem Cells (iPSCs) Market Scope
- Blood Cells
- Skin Cells
- Mouse iPSCs
- Human iPSCs
- Instruments
- Services
- Consumables & Kits
- Others
- Diagnostic Laboratories
- Research Laboratories
- Biotechnology & Pharmaceutical Companies
- Retail Sales
- Direct Tender
- Others
- 3D Bioprinting
- Stem Cell Banking
- Toxicology Screening
- Regenerative Medicine
- Cellular Therapy
- Disease Modelling
- Academic Research
- Drug Discovery And Development
Frequently Asked Questions
Netherlands Induced Pluripotent Stem Cells (iPSCs) Market Company Profiling
Frequently Asked Questions
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.